ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 815,92
-1,49%
DAX
17 932,17
-1,10%
Brent Oil
85,495
-0,47%
Bitcoin
59 825,44
-1,28%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. BioCardia Inc (BCDA)

  7. BioCardia Inc (BCDA) Actualités

BCDA BioCardia Inc

0,3803
0,0103 (2,78%)
01 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
BioCardia Inc BCDA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,0103 2,78% 0,3803 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,37 0,37 0,40 0,3871 0,37
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/4/202415:00GLOBEBioCardia Completes Enrollment of CardiAMP Cell Therapy for..
27/3/202421:00GLOBEBioCardia Reports Fourth Quarter and Full Year 2023 Business..
20/3/202412:00GLOBEBioCardia to Host 2023 Financial Results and Corporate..
13/3/202412:00GLOBEBioCardia and StemCardia Announce Biotherapeutic Delivery..
12/3/202412:00GLOBEBioCardia Announces CMS Approval of Coverage for CardiAMP..
04/3/202414:00EDGAR2Form 8-K - Current report
04/3/202414:00GLOBEBioCardia Reports Positive Interim Results from Phase III..
27/2/202422:53EDGAR2Form SC 13D/A - General statement of acquisition of..
15/2/202413:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:17EDGAR2Form S-3 - Registration statement under Securities Act of..
09/2/202415:58EDGAR2Form 8-K - Current report
08/2/202413:03EDGAR2Form 8-K - Current report
08/2/202413:00GLOBEBioCardia Announces Activation of CardiAMP Heart Failure II..
06/2/202422:28EDGAR2Form SC 13D/A - General statement of acquisition of..
02/2/202420:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
31/1/202413:00EDGAR2Form 8-K - Current report
31/1/202413:00GLOBEBioCardia Announces Two Scientific Abstracts Have Been..
03/1/202413:00EDGAR2Form 8-K - Current report
03/1/202413:00GLOBEBioCardia Biotherapeutic Delivery and Morph Access..
19/12/202313:00EDGAR2Form 8-K - Current report
19/12/202313:00GLOBEBioCardia Doses First Patient in CardiALLO Phase I/II..
18/12/202313:16GLOBEBioCardia Announces Expected CardiAMP Heart Failure Japan..
18/12/202313:00EDGAR2Form 8-K - Current report
06/12/202312:05EDGAR2Form 8-K - Current report
06/12/202312:03EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
06/12/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
05/12/202322:11EDGAR2Form 8-K/A - Current report: [Amend]
05/12/202322:05EDGAR2Form 8-K - Current report
29/11/202313:00EDGAR2Form 8-K - Current report
29/11/202313:00GLOBEBioCardia Shares Update from Japan PMDA Consultation on..
17/11/202323:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16/11/202323:15EDGAR2Form 8-K - Current report
16/11/202318:56GLOBEBioCardia Announces $1.3 Million Registered Direct Offering..
14/11/202313:15GLOBEBioCardia Announces FDA Approval of CardiAMP Heart Failure..
08/11/202322:11GLOBEBioCardia Reports Third Quarter 2023 Business Highlights and..
08/11/202322:08EDGAR2Form 8-K - Current report
08/11/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202322:04GLOBEBioCardia to Host Q3 2023 Corporate Update and Financial..
20/10/202315:26EDGAR2Form S-3 - Registration statement under Securities Act of..
19/10/202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202323:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202323:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/10/202323:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/10/202322:30EDGAR2Form 8-K - Current report
11/10/202312:04EDGAR2Form 8-K - Current report
11/10/202312:00GLOBEBioCardia Announces Completion of Enrollment in Phase III..

Dernières Valeurs Consultées

NASDAQ
BCDA
BioCardia
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés